GE fourth quarter & full year 2022 performance Financial results & company highlights January 24, 2023 CAUTION CONCERNING FORWARD-LOOKING STATEMENTS: This document contains "forward-looking statements" – that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain. For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, see https://www.ge.com/investor-relations/important-forward-looking-statement-information as well as our annual reports on Form 10-K and quarterly reports on Form 10-Q. We do not undertake to update our forward-looking statements. This document also includes certain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ materially. NON-GAAP FINANCIAL MEASURES: In this document, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP). Certain of these data are considered “non-GAAP financial measures” under the U.S. Securities and Exchange Commission rules. These non-GAAP financial measures supplement our GAAP disclosures and should not be considered an alternative to the GAAP measure. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in our earnings release and the appendix of this presentation and prior earnings presentations, as applicable. Amounts shown on subsequent pages may not add due to rounding. Unless otherwise stated, these financial results are shown including GE HealthCare in continuing operations as of December 31, 2022. GE’s Investor Relations website at www.ge.com/investor and our corporate blog at www.gereports.com, as well as GE’s Facebook page and Twitter accounts, contain a significant amount of information about GE, including financial and other information for investors. GE encourages investors to visit these websites from time to time, as information is updated and new information is posted. -- 1 of 39 -- A new era begins ... Strong 4Q finish & successful GE HealthCare spin Strong GE Aerospace results GE Vernova: improving with Power delivering & Renewable Energy taking action -- 2 of 39 -- 2022 snapshot Adjusted revenue* FY'22 Adjusted profit margin* Adjusted EPS* Free cash flow* Orders GE, including GE HealthCare Significant growth, margin, EPS & FCF* improvement 3 4Q'22 +18% +11% +290 bps $4.3B $1.24 +7% +6% +160 bps $4.8B $2.62 +$0.91, +53% +$2.1B-b), +81% * Non-GAAP Financial Measure (a– Year-over-year variances for orders, revenue and margin are presented on an organic basis (b– Excludes prior period CFOA impact from discontinued factoring programs $25.4B $21.0B 10.3% +$0.42, +51% +$0.6B, +16% $83.0B $73.6B 7.9% Y/Y VARIANCE-a)RESULTS Y/Y VARIANCE-a)RESULTS -- 3 of 39 -- • Orders: $9.7B, +26% … Commercial Services & Military equipment • Revenue: $7.6B, +26% * ... services, notably Commercial, & equipment from higher LEAP engine deliveries • Margin: 18.8%, (150)bps * ... volume & price offsetting negative engine mix, investment & other costs * Non-GAAP Financial Measure (a– Year-over-year variances for orders, revenue and margin are presented on an organic basis (b– Excludes prior period CFOA impact from discontinued factoring programs 4Q'22 RESULTS 4Q'22 DYNAMICS-a) GE Aerospace ($ in billions) Rev. Growthorg* 4% 12% 27% 25% 26% Profit $ 1.2 0.9 1.1 1.3 1.4 4 FY'23 OUTLOOK • Organic revenue growth*: mid to high teens • Operating profit: $5.3B-$5.7B • FCF*: up; earnings & W/C partially offset by ~$(0.5)B AD&A • FY'22 FCF*: $4.9B … earnings & W/C; +$0.3B -b) y/y -- 4 of 39 -- • Orders: $5.0B, +7% ... equipment growth from Grid & Onshore in North America • Revenue: $3.4B, (13)%* … lower Onshore deliveries • Margin: (13.3)%, (260)bps * … Grid improvement offset by Onshore volume pressure & inflation across businesses • FY'22 FCF*: $(2.0)B ... earnings; $(0.8)B -b) y/y 2Q21 2Q20 ($ in billions) 4Q'22 RESULTS 4Q'22 DYNAMICS-a) Rev. Growthorg* (5)% (10)% (20)% (10)% (13)% Profit $ (0.3) (0.4) (0.4) (0.9) (0.5) Renewable Energy part of GE Vernova, GE's portfolio of energy businesses 5 • Organic revenue growth*: +MSD • Operating profit: significantly better • FCF*: flat to improving; earnings growth with flat W/C * Non-GAAP Financial Measure (a– Year-over-year variances for orders, revenue and margin are presented on an organic basis (b– Excludes prior period CFOA impact from discontinued factoring programs FY'23 OUTLOOK -- 5 of 39 -- • Orders: $5.4B, +29% … higher Aeroderivatives equipment & transactional services growth • Revenue: $5.0B, +12% * ... Aeroderivative equipment & total services growth • Margin: 13.8%, +710bps * … higher volume, better price/cost & productivity • FY'22 FCF*: $1.9B ... earnings & W/C; +$0.7B -b) y/y 2Q21 2Q20 Power part of GE Vernova, GE's portfolio of energy businesses 4Q'22 RESULTS 4Q'22 DYNAMICS-a) Rev. Growthorg* (10) % (6)% 4% (5)% 12% Profit $ 0.3 0.1 0.3 0.1 0.7 ($ in billions) 6 • Organic revenue growth*: +LSD • Operating profit: slightly better • FCF*: lower; earnings growth offset by disbursements * Non-GAAP Financial Measure (a– Year-over-year variances for orders, revenue and margin are presented on an organic basis (b– Excludes prior period CFOA impact from discontinued factoring programs FY'23 OUTLOOK -- 6 of 39 -- FY 2023 Outlook Confident in strong market demand & operational improvements across businesses GE AEROSPACE Mid-to-high teens growth, $5.3B-$5.7B profit, FCF* up • High-teens to ~20% Commercial Services & ~20% engines growth, +HSD Military growth • Profit: volume, price + productivity > mix + inflation • Mix pressuring margin rate 7 GE, excluding GE HealthCare GE VERNOVA -a) LSD to MSD growth, $(0.6)B-$(0.2)B profit, FCF* flat to slightly improved • Renewable Energy: Onshore better... price & cost actions, large 2H down payments; Offshore growth • Power: Gas outage volume higher; Gas equipment growth; profit: volume, productivity + price > inflation 2023 OUTLOOK Adjusted EPS* $0.77 Free cash flow* $3.1B Organic revenue growth* +6% 2022 EX-GEHC +HSD $3.4B-$4.2B $1.60-$2.00 * Non-GAAP Financial Measure Revenue assumptions on organic basis. '22 GE excluding HealthCare: Adjusted revenues* $55.1B, Adjusted profit* $3.2B, Adjusted profit margin* 5.7% Expect '23 interest expense ~$(1)B, adjusted tax rate* mid-20s; adjusted corporate cost* ~flat, corporate FCF* significantly better (a– For the purposes of 2023 Outlook, GE Vernova refers to the sum of our Renewable Energy and Power segments, without giving effect to eliminations and Corporate adjustments. -- 7 of 39 -- Building momentum toward independent industry leaders 8 Driving continued growth in 2023 GE Aerospace executing on ramp with significant profit growth Leading in critical growth sectors ... Future of Flight & Energy Transition GE Vernova making progress & preparing to spin -- 8 of 39 -- Q&A 9 CFM signed an agreement for Air France KLM Engineering & Maintenance to provide the full scope of LEAP MRO services for operators worldwide Gas Power secured an order from the Swiss Federal Office of Energy, renting eight mobile aeroderivative gas turbine units to help meet electricity demand during the critical period near end of winter -- 9 of 39 -- Appendix 11 HealthCare Operating segment results 12 TY Operating segment results 13 Orders $ 14 Backlog $ 15 Revenue $ 16 Orders and Sales units 17 FCF 18 FCF details 10 -- 10 of 39 -- GE HealthCare (NASDAQ: GEHC) spun off from GE on January 3, 2023 and is now a standalone company that will release its financial results in connection with their earnings call on January 30, 2023. 2Q21 2Q20 GE HealthCare ($ in billions) 4Q'22 RESULTS (GE basis) * Non-GAAP Financial Measure Rev. Growthorg* (4)% 2% 4% 10% 12% Profit $ 0.8 0.5 0.7 0.7 0.8 11 -- 11 of 39 -- HEALTHCARE (GE basis) RENEWABLES 2022 Operating segments results POWER AEROSPACE * Non-GAAP Financial Measure (a– Excludes prior period CFOA impact from discontinued factoring programs $ / % y/y (org.)* $ / % y/y (org.)* $ / % y/y (org.)* $ / % y/y (org.)* Orders $31.1 22% $14.7 (17)% $17.8 13% $19.9 4% Revenue $26.0 23% $13.0 (13)% $16.3 2% $18.5 7% Segment profit $4.8 62% $(2.2) U $1.2 69% $2.7 (2)% Segment margin 18.3% 440bps (17.3)% (1,150)bps 7.5% 300bps 14.7% (150)bps FCF* -a) $4.9 $0.3 $(2.0) $(0.8) $1.9 $0.7 $2.1 $(0.6) 12 ($ in billions) GE results, including GE HealthCare -- 12 of 39 -- Orders - supplemental information 4Q'22 y/y (org.) FY'22 y/y (org.) 4Q'22 y/y (org.) FY'22 y/y (org.) 4Q'22 y/y (org.) FY'22 y/y (org.) Aerospace $4.4 48% $11.4 17% $5.3 12% $19.7 25% $9.7 26% $31.1 22% Renewable Energy $4.5 12% $12.3 (17)% $0.5 (23)% $2.4 (20)% $5.0 7% $14.7 (17)% Power $1.7 57% $5.5 29% $3.7 20% $12.4 6% $5.4 29% $17.8 13% HealthCare $3.1 2% $11.2 3% $2.2 8% $8.6 7% $5.3 5% $19.9 4% Total Company $13.6 24% $39.9 1% $11.8 11% $43.1 12% $25.4 18% $83.0 7% EQUIPMENT ORDERS SERVICE ORDERS TOTAL ORDERS 13 ($ in billions) GE results, including GE HealthCare -- 13 of 39 -- 4Q'22 y/y 4Q'22 y/y 4Q'22 y/y Aerospace $39.7 9% $312.9 17% $352.6 16% Renewable Energy $20.1 8% $12.7 (1)% $32.8 4% Power $13.4 (6)% $60.9 2% $74.3 —% HealthCare $7.2 12% $11.7 (8)% $18.9 (1)% Total Company $79.3 6% $399.0 13% $478.2 12% 14 Backlog - supplemental information ($ in billions) GE results, including GE HealthCare EQUIPMENT BACKLOG SERVICE BACKLOG TOTAL BACKLOG -- 14 of 39 -- Revenues - supplemental information 4Q'22 y/y (org.)* FY'22 y/y (org.)* 4Q'22 y/y (org.)* FY'22 y/y (org.)* 4Q'22 y/y (org.)* FY'22 y/y (org.)* Aerospace $2.5 26% $7.8 5% $5.2 26% $18.2 32% $7.6 26% $26.0 23% Renewable Energy $2.7 (14)% $10.2 (19)% $0.7 (7)% $2.8 15% $3.4 (13)% $13.0 (13)% Power $1.6 27% $4.7 —% $3.4 6% $11.5 3% $5.0 12% $16.3 2% HealthCare $2.7 16% $9.6 8% $2.3 8% $8.8 6% $5.0 12% $18.5 7% Total Company $9.4 9% $32.0 (4)% $11.6 13% $41.6 16% $21.0 11% $73.6 6% * Non-GAAP Financial Measure (a– Adjusted revenues* (Total revenues less Insurance) -a)* 15 EQUIPMENT REVENUES SERVICE REVENUES TOTAL REVENUES ($ in billions) GE results, including GE HealthCare -a)* -- 15 of 39 -- Orders and Sales - supplemental information, units (a– LEAP engines are a subset of Commercial Engines (b– Includes Onshore and Offshore units (c– Gigawatts reported associated with orders and sales in the periods presented (d– Heavy-Duty Gas Turbines and Aeroderivatives are subsets of GE Gas Turbines (e– HA-Turbines are a subset of Heavy-Duty Gas Turbines (f– Commercial externally shipped spares and spares used in time & material shop visits in millions of dollars per day (in units) 4Q'22 4Q'21 FY22 FY21 Aerospace Commercial Engines 824 977 2,127 2,248 LEAP Engines -a) 579 591 1,515 1,457 Military Engines 373 55 532 723 Renewable Energy Wind Turbines-b) 1,011 645 2,243 2,860 Wind Turbine Gigawatts-b),-c) 3.2 3.1 7.8 12.1 Repower units — 141 411 786 Power GE Gas Turbines 32 27 92 123 Heavy-Duty Gas Turbines -d) 13 22 30 65 HA-Turbines -e) 1 4 9 10 Aeroderivatives -d) 19 5 62 58 GE Gas Turbine Gigawatts -c) 2.9 4.2 9.8 12.6 16 4Q'22 4Q'21 FY22 FY21 Aerospace Commercial Engines 476 368 1,663 1,487 LEAP Engines -a) 324 220 1,136 845 Military Engines 166 148 632 553 Spares rate -f) ($ in millions) 31.9 23.8 26.9 17.8 Renewable Energy Wind Turbines-b) 487 842 2,190 3,590 Wind Turbine Gigawatts -b),-c) 1.8 2.8 7.5 11.7 Repower units 165 285 580 561 Power GE Gas Turbines 32 15 101 62 Heavy-Duty Gas Turbines -d) 16 9 53 43 HA-Turbines-e) 5 2 11 13 Aeroderivatives -d) 16 6 48 19 ORDERS SALES -- 16 of 39 -- • Positive contribution from earnings & working capital … y/y improvement from earnings and debt reduction • $4.9B Aerospace … +$0.3B y/y driven by earnings growth offsetting working capital and AD&A pressure • $(2.0)B Renewables … $(0.8)B y/y due to lower earnings • $1.9B Power ... +$0.7B y/y driven by Gas earnings growth, services billings and Steam • $2.1B HealthCare (GE basis) … $(0.6)B y/y driven by supply chain challenges pressuring profit and working capital • $(2.1)B Corporate, including $(1.4)B interest cash … +$2.6B y/y driven by lower costs and debt reduction Free cash flow* performance * Non-GAAP Financial Measure (a– Aggregates the following: Net earnings (loss) and (earnings) loss from discontinued operations (b– Excludes CFOA impact from receivables factoring and supply chain finance eliminations in the prior year (c– Includes the following: (Gains) losses on sales of business interests, (Gains) losses on equity securities, debt extinguishment costs, principal pension plans (net), other post retirement benefit plans (net), income taxes (net), financial services derivatives and all other operating; excludes Insurance CFOA, separation cash expenditures, Corporate restructuring cash expenditures and deal taxes (d– Excludes prior period CFOA impact from discontinued factoring programs FY'22 DYNAMICS4Q'22 y/y FY'22 y/y Net earnings (loss) -a) 2.3 5.8 0.9 4.3 Debt extinguishment costs 0.5 (4.6) 0.5 (6.1) Depreciation & amortization 0.7 (0.0) 3.5 0.5 Operating working capital 2.7 0.4 1.4 0.1 Current receivables -b) (0.3) (1.0) (3.0) (5.2) Inventory 0.4 (0.0) (2.3) (1.6) Accounts payable -b) 0.7 0.5 2.8 2.9 Progress collections 1.2 0.7 2.5 3.5 Current contract assets 0.7 0.2 1.5 0.4 Other CFOA-b),-c) (1.5) (0.9) (0.1) 4.1 Gross CAPEX (0.4) (0.1) (1.5) (0.1) FCF* 4.3 0.6 4.8 2.9 FCF ex disc. factoring* -d) 4.3 0.6 4.8 2.1 ($ in billions) GE results, including GE HealthCare 17 -- 17 of 39 -- 2022 Free cash flow* details 2022 1Q'22 2Q'22 3Q'22 4Q'22 Total Company Aerospace Renewables Power HealthCare Corporate Net earnings (loss)-a) (0.7) (0.6) (0.1) 2.3 0.9 3.9 (2.2) 0.9 2.1 (3.8) Debt extinguishment costs — — — 0.5 0.5 — — — — 0.5 Depreciation & amortization 1.5 0.7 0.6 0.7 3.5 1.0 0.4 0.5 0.6 0.9 Operating working capital (1.0) (0.2) (0.2) 2.7 1.4 0.4 0.0 0.5 (0.2) 0.6 Other CFOA-b) (0.3) 0.5 1.1 (1.5) (0.1) 0.1 0.0 0.1 (0.1) (0.3) Gross capex (0.4) (0.3) (0.3) (0.4) (1.5) (0.6) (0.3) (0.2) (0.3) 0.0 FCF* (0.9) 0.2 1.2 4.3 4.8 4.9 (2.0) 1.9 2.1 (2.1) * Non-GAAP Financial Measure (a– Aggregates the following: Net earnings (loss) and (earnings) loss from discontinued operations (b– Includes the following: (Gains) losses on sales of business interests, (Gains) losses on equity securities, debt extinguishment costs, principal pension plans (net), other post retirement benefit plans (net), income taxes (net), financial services derivatives and all other operating; excludes Insurance CFOA, separation cash expenditures, Corporate restructuring cash expenditures and deal taxes 18 ($ in billions) GE results, including GE HealthCare -- 18 of 39 -- Non-GAAP reconciliations 19 20 Organic revenues, profit (loss) & profit margin by segment 21 Organic revenues, including and excluding GE HealthCare 22 Organic revenues by sub segment 23 Equipment & service organic revenues 24 Equipment & service organic revenues by sub segment 25 Adjusted profit & profit margin 26 Adjusted profit & profit margin excluding GE HealthCare 27 Adjusted organic profit & profit margin 28 Adjusted earnings (loss) and Adjusted earnings (loss) per share 29 Adjusted earnings (loss) and Adjusted earnings (loss) per share excluding GE HealthCare 30 Adjusted income tax rate and Adjusted earnings from continuing operations before income taxes 31 Free cash flows (FCF) (including and excluding discontinued factoring) and Free cash flows (FCF) excluding GE HealthCare 32 Free cash flows (FCF) by quarter (incl and excl disc factoring) 33 Free cash flows (FCF) by segment (incl and excl disc factoring) 34 Adjusted Corporate costs 35 Net debt 36 Net debt excluding GE HealthCare 37 Leverage EBITDA & net debt/EBITDA ratio 38 Leverage EBTIDA & net debt/EBITDA ratio excluding GE HealthCare -- 19 of 39 -- 20 Organic revenues, profit (loss) and profit margin by segment * Non-GAAP Financial Measure We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP) REVENUES PROFIT (LOSS) PROFIT MARGIN REVENUES PROFIT (LOSS) PROFIT MARGIN (Dollars in millions) 4Q'22 4Q'21 V% 4Q'22 4Q'21 V% 4Q'22 4Q'21 V pts 2022 2021 V% 2022 2021 V% 2022 2021 V pts Aerospace (GAAP) $ 7,615 $ 6,080 25 % $ 1,434 $ 1,218 18 % 18.8 % 20.0 % (1.2)pts $ 26,050 $ 21,310 22 % $ 4,775 $ 2,882 66 % 18.3 % 13.5 % 4.8pts Less: acquisitions — — — — — — — — Less: business dispositions — — — — — — — — Less: foreign currency effect (29) (1) 12 (2) (80) — 101 3 Aerospace organic (Non-GAAP) $ 7,645 $ 6,082 26 % $ 1,421 $ 1,221 16 % 18.6 % 20.1 % (1.5)pts $ 26,129 $ 21,311 23 % $ 4,674 $ 2,879 62 % 17.9 % 13.5 % 4.4pts Renewable Energy (GAAP) $ 3,413 $ 4,192 (19)% $ (454) $ (312) (46)% (13.3)% (7.4)% (5.9)pts $ 12,977 $ 15,697 (17)% $ (2,240) $ (795) U (17.3)% (5.1)% (12.2)pts Less: acquisitions — (12) — (4) — (55) — (17) Less: business dispositions — — — — — — — — Less: foreign currency effect (260) 2 (18) 81 (702) 2 55 52 Renewable Energy organic (Non- GAAP) $ 3,673 $ 4,202 (13)% $ (435) $ (388) (12)% (11.8)% (9.2)% (2.6)pts $ 13,678 $ 15,749 (13)% $ (2,295) $ (831) U (16.8)% (5.3)% (11.5)pts Power (GAAP) $ 5,030 $ 4,661 8 % $ 692 $ 309 F 13.8 % 6.6 % 7.2pts $ 16,262 $ 16,903 (4)% $ 1,217 $ 726 68 % 7.5 % 4.3 % 3.2pts Less: acquisitions — — — — — — — — Less: business dispositions — 26 — (2) — 502 — (2) Less: foreign currency effect (182) (1) (54) (24) (503) (5) (78) (40) Power organic (Non-GAAP) $ 5,212 $ 4,636 12 % $ 746 $ 336 F 14.3 % 7.2 % 7.1pts $ 16,765 $ 16,405 2 % $ 1,295 $ 768 69 % 7.7 % 4.7 % 3.0pts HealthCare (GAAP) $ 4,966 $ 4,625 7 % $ 804 $ 762 6 % 16.2 % 16.5 % (0.3)pts $ 18,461 $ 17,725 4 % $ 2,705 $ 2,966 (9)% 14.7 % 16.7 % (2.0)pts Less: acquisitions 63 — 2 (11) 238 — (54) (16) Less: business dispositions — — — — — — — — Less: foreign currency effect (288) — (79) 3 (772) — (169) (14) HealthCare organic (Non-GAAP) $ 5,191 $ 4,625 12 % $ 881 $ 770 14 % 17.0 % 16.6 % 0.4pts $ 18,994 $ 17,725 7 % $ 2,928 $ 2,995 (2)% 15.4 % 16.9 % (1.5)pts -- 20 of 39 -- 21 Organic revenues and Organic revenues excluding GE HealthCare ORGANIC REVENUES (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Total revenues (GAAP) $ 21,786 $ 20,303 7 % $ 76,555 $ 74,196 3 % Less: Insurance revenues 775 811 2,954 3,106 Adjusted revenues (Non-GAAP) $ 21,011 $ 19,492 8 % $ 73,602 $ 71,090 4 % Less: acquisitions 64 (12) 241 (55) Less: business dispositions — (21) — 158 Less: foreign currency effect (765) — (2,079) (3) Organic revenues (Non-GAAP) $ 21,713 $ 19,525 11 % $ 75,440 $ 70,989 6 % ORGANIC REVENUES EXCLUDING GE HEALTHCARE (NON-GAAP) (Dollars in millions) 2022 2021 V% Total revenues excluding GE HealthCare (GAAP) $ 58,096 $ 56,474 3 % Less: Insurance revenues 2,954 3,106 Adjusted revenues excluding GE HealthCare (Non-GAAP) $ 55,143 $ 53,368 3 % Less: acquisitions 2 (55) Less: business dispositions — 158 Less: foreign currency effect (1,307) (2) Organic revenues excluding GE HealthCare (Non-GAAP) $ 56,448 $ 53,267 6 % * Non-GAAP Financial Measure We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of revenues from our run-off Insurance business, acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023. -- 21 of 39 -- 22 Organic revenues by sub segment ORGANIC REVENUES BY SUB SEGMENT (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Aerospace commercial services revenues (GAAP) $ 3,680 $ 2,864 28 % $ 12,858 $ 8,995 43 % Less: acquisitions — — — — Less: business dispositions — — — — Less: foreign currency effect — — — — Aerospace commercial services organic revenues (Non-GAAP) $ 3,680 $ 2,864 28 % $ 12,858 $ 8,995 43 % Aerospace commercial engines revenues (GAAP) $ 1,855 $ 1,425 30 % $ 5,807 $ 5,365 8 % Less: acquisitions — — — — Less: business dispositions — — — — Less: foreign currency effect — — — — Aerospace commercial engines organic revenues (Non-GAAP) $ 1,855 $ 1,425 30 % $ 5,807 $ 5,365 8 % Aerospace military revenues (GAAP) $ 1,251 $ 1,032 21 % $ 4,410 $ 4,136 7 % Less: acquisitions — — — — Less: business dispositions — — — — Less: foreign currency effect — — — — Aerospace military organic revenues (Non-GAAP) $ 1,251 $ 1,032 21 % $ 4,410 $ 4,136 7 % * Non-GAAP Financial Measure We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. -- 22 of 39 -- 23 Equipment & service organic revenues EQUIPMENT AND SERVICES ORGANIC REVENUES (NON-GAAP) EQUIPMENT SERVICES (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% 4Q'22 4Q'21 V% 2022 2021 V% Aerospace revenues (GAAP) $ 2,463 $ 1,982 24 % $ 7,842 $ 7,531 4 % $ 5,152 $ 4,099 26 % $ 18,207 $ 13,780 32 % Less: acquisitions — — — — — — — — Less: business dispositions — — — — — — — — Less: foreign currency effect (28) — (43) — (1) (1) (36) — Aerospace organic revenues (Non-GAAP) $ 2,491 $ 1,982 26% $ 7,885 $ 7,531 5% $ 5,153 $ 4,099 26% $ 18,244 $ 13,780 32% Renewable Energy revenues (GAAP) $ 2,686 $ 3,380 (21)% $ 10,191 $ 13,224 (23)% $ 727 $ 812 (10)% $ 2,785 $ 2,473 13 % Less: acquisitions — — — — — (12) — (55) Less: business dispositions — — — — — — — — Less: foreign currency effect (216) 2 (579) 2 (43) — (123) — Renewable Energy organic revenues (Non-GAAP) $ 2,903 $ 3,378 (14)% $ 10,771 $ 13,222 (19)% $ 770 $ 824 (7)% $ 2,908 $ 2,527 15 % Power revenues (GAAP) $ 1,621 $ 1,354 20 % $ 4,737 $ 5,035 (6)% $ 3,409 $ 3,307 3 % $ 11,526 $ 11,868 (3)% Less: acquisitions — — — — — — — — Less: business dispositions — — — — — 26 — 502 Less: foreign currency effect (103) — (275) (2) (79) — (228) (2) Power organic revenues (Non-GAAP) $ 1,725 $ 1,355 27 % $ 5,012 $ 5,037 — % $ 3,487 $ 3,281 6 % $ 11,754 $ 11,368 3 % HealthCare revenues (GAAP) $ 2,698 $ 2,434 11 % $ 9,643 $ 9,104 6 % $ 2,269 $ 2,191 4 % $ 8,818 $ 8,620 2 % Less: acquisitions 33 — 207 — 30 — 31 — Less: business dispositions — — — — — — — — Less: foreign currency effect (154) — (400) — (134) — (372) — HealthCare organic revenues (Non-GAAP) $ 2,818 $ 2,434 16 % $ 9,836 $ 9,105 8 % $ 2,373 $ 2,191 8 % $ 9,158 $ 8,620 6 % Total revenues (GAAP) $ 9,427 $ 9,029 4 % $ 31,976 $ 34,200 (7)% $ 11,584 $ 10,464 11 % $ 41,626 $ 36,890 13 % Less: acquisitions 33 — 207 — 30 (12) 34 (55) Less: business dispositions — (32) — (177) — 11 — 336 Less: foreign currency effect (508) 1 (1,319) — (257) (1) (760) (2) Total organic revenues (Non-GAAP) $ 9,901 $ 9,059 9 % $ 33,088 $ 34,378 (4)% $ 11,811 $ 10,466 13 % $ 42,352 $ 36,612 16 % * Non-GAAP Financial Measure We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. -- 23 of 39 -- 24 Equipment & service organic revenues by sub segment EQUIPMENT AND SERVICES ORGANIC REVENUES BY SUB SEGMENT (NON-GAAP) EQUIPMENT SERVICES (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% 4Q'22 4Q'21 V% 2022 2021 V% Gas Power revenues (GAAP) $ 1,241 $ 850 46 % $ 3,460 $ 3,220 7 % $ 2,597 $ 2,491 4 % $ 8,612 $ 8,860 (3)% Less: acquisitions — — — — — — — — Less: business dispositions — — — — — 26 — 502 Less: foreign currency effect (62) (1) (151) (3) (16) (1) (53) (3) Gas Power organic revenues (Non-GAAP) $ 1,304 $ 851 53 % $ 3,611 $ 3,223 12 % $ 2,613 $ 2,465 6 % $ 8,665 $ 8,360 4 % Steam Power revenues (GAAP) $ 261 $ 373 (30)% $ 892 $ 1,260 (29)% $ 484 $ 542 (11)% $ 1,751 $ 1,981 (12)% Less: acquisitions — — — — — — — — Less: business dispositions — — — — — — — — Less: foreign currency effect (31) — (96) — (46) — (132) — Steam Power organic revenues (Non-GAAP) $ 292 $ 373 (22)% $ 988 $ 1,260 (22)% $ 530 $ 542 (2)% $ 1,884 $ 1,981 (5)% Power Conversion, Nuclear and other revenues (GAAP) $ 119 $ 132 (10)% $ 385 $ 555 (31)% $ 328 $ 274 20 % $ 1,162 $ 1,027 13 % Less: acquisitions — — — — — — — — Less: business dispositions — — — — — — — — Less: foreign currency effect (10) — (27) — (16) — (42) 1 Power Conversion, Nuclear and other organic revenues (Non-GAAP) $ 129 $ 131 (2)% $ 412 $ 554 (26)% $ 344 $ 274 26 % $ 1,205 $ 1,027 17 % * Non-GAAP Financial Measure We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. -- 24 of 39 -- 25 Adjusted profit & profit margin ADJUSTED PROFIT AND PROFIT MARGIN (EXCLUDING CERTAIN ITEMS) (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Total revenues (GAAP) $ 21,786 $ 20,303 7 % $ 76,555 $ 74,196 3 % Less: Insurance revenues 775 811 2,954 3,106 Adjusted revenues (Non-GAAP) $ 21,011 $ 19,492 8 % $ 73,602 $ 71,090 4 % Total costs and expenses (GAAP) $ 21,721 $ 24,836 (13) % $ 76,375 $ 80,702 (5) % Less: Insurance cost and expenses 802 671 2,894 2,540 Less: interest and other financial charges 407 410 1,552 1,813 Less: non-operating benefit cost (income) (136) 408 (532) 1,782 Less: restructuring & other 693 54 949 455 Less: debt extinguishment costs 465 5,108 465 6,524 Less: separation costs 419 — 973 — Less: Steam asset sale impairment (1) — 824 — Less: Russia and Ukraine charges — — 263 — Add: noncontrolling interests 16 1 67 (71) Add: EFS benefit from taxes (53) (51) (213) (162) Adjusted costs (Non-GAAP) $ 19,035 $ 18,135 5 % $ 68,840 $ 67,354 2 % Other income (loss) (GAAP) $ 2,172 $ 1,066 F $ 1,231 $ 2,823 (56) % Less: gains (losses) on equity securities 1,935 665 76 1,921 Less: restructuring & other 28 68 31 75 Less: gains (losses) on purchases and sales of business interests 24 115 51 (44) Adjusted other income (loss) (Non-GAAP) $ 186 $ 218 (15) % $ 1,074 $ 871 23 % Profit (loss) (GAAP) $ 2,237 $ (3,467) F $ 1,412 $ (3,683) F Profit (loss) margin (GAAP) 10.3 % (17.1) % 27.4 pts 1.8 % (5.0) % 6.8 pts Adjusted profit (loss) (Non-GAAP) $ 2,162 $ 1,575 37 % $ 5,835 $ 4,608 27 % Adjusted profit (loss) margin (Non-GAAP) 10.3 % 8.1 % 2.2 pts 7.9 % 6.5 % 1.4 pts * Non-GAAP Financial Measure We believe that adjusting profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. -- 25 of 39 -- 26 Adjusted profit & profit margin excluding GE HealthCare ADJUSTED PROFIT AND PROFIT MARGIN (EXCLUDING CERTAIN ITEMS) EXCLUDING GE HEALTHCARE (NON-GAAP) (Dollars in millions) 1Q'22 2022 Total revenues excluding GE HealthCare (GAAP) $ 12,678 $ 58,096 Less: Insurance revenues 767 2,954 Adjusted revenues excluding GE HealthCare (Non-GAAP) $ 11,910 $ 55,143 Total costs and expenses excluding GE HealthCare (GAAP) $ 13,788 $ 60,212 Less: Insurance cost and expenses 543 2,894 Less: interest and other financial charges 371 1,423 Less: non-operating benefit cost (income) (105) (409) Less: restructuring & other 38 836 Less: debt extinguishment costs — 465 Less: separation costs 99 715 Less: Steam asset sale impairment 824 824 Less: Russia and Ukraine charges 230 263 Add: noncontrolling interests 14 16 Add: EFS benefit from taxes (47) (213) Adjusted costs excluding GE HealthCare (Non-GAAP) $ 11,755 $ 53,004 Other income (loss) excluding GE HealthCare (GAAP) $ 49 $ 1,172 Less: gains (losses) on equity securities (219) 76 Less: restructuring & other 3 31 Less: gains (losses) on purchases and sales of business interests 4 45 Adjusted other income (loss) excluding GE HealthCare (Non-GAAP) $ 260 $ 1,020 Profit (loss) excluding GE HealthCare (GAAP) $ (1,062) $ (944) Profit (loss) margin excluding GE HealthCare (GAAP) (8.4) % (1.6) % Adjusted profit (loss) excluding GE HealthCare (Non-GAAP) $ 415 $ 3,159 Adjusted profit (loss) margin excluding GE HealthCare (Non-GAAP) 3.5 % 5.7 % * Non-GAAP Financial Measure We believe that adjusting profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023. -- 26 of 39 -- 27 Adjusted organic profit and profit margin ADJUSTED ORGANIC PROFIT (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Adjusted profit (loss) (Non-GAAP) $ 2,162 $ 1,575 37 % $ 5,835 $ 4,608 27 % Less: acquisitions 2 (15) (72) (32) Less: business dispositions — 1 — 14 Less: foreign currency effect (139) 90 (104) 70 Adjusted organic profit (loss) (Non-GAAP) $ 2,299 $ 1,498 53 % $ 6,011 $ 4,556 32 % Adjusted profit (loss) margin (Non-GAAP) 10.3 % 8.1 % 220 bps 7.9 % 6.5 % 140 bps Adjusted organic profit (loss) margin (Non-GAAP) 10.6 % 7.7 % 290 bps 8.0 % 6.4 % 160 bps * Non-GAAP Financial Measure We believe this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional impacts, as these activities can obscure underlying trends. -- 27 of 39 -- 28 Adjusted earnings (loss) and Adjusted earnings (loss) per share ADJUSTED EARNINGS (LOSS) (NON-GAAP) 4Q'22 4Q'21 V% 2022 2021 V% (Dollars in millions, per-share amounts in dollars) Earnings EPS Earnings EPS Earnings EPS Earnings EPS Earnings EPS Earnings EPS Earnings (loss) from continuing operations (GAAP) $ 2,178 1.99 $ (3,561) (3.24) F F $ 584 0.53 $ (3,571) (3.25) F F Insurance earnings (loss) (pre-tax) (26) (0.02) 140 0.13 65 0.06 570 0.52 Tax effect on Insurance earnings (loss) 3 — (30) (0.03) (21) (0.02) (126) (0.11) Less: Insurance earnings (loss) (net of tax) (24) (0.02) 110 0.10 44 0.04 444 0.40 Earnings (loss) per share excluding Insurance (Non-GAAP) $ 2,202 2.01 $ (3,670) (3.34) F F $ 540 0.49 $ (4,015) (3.66) F F Non-operating benefit (cost) income (pre-tax) (GAAP) 136 0.12 (408) (0.37) 532 0.48 (1,782) (1.62) Tax effect on non-operating benefit (cost) income (29) (0.03) 86 0.08 (112) (0.10) 374 0.34 Less: Non-operating benefit (cost) income (net of tax) 107 0.10 (323) (0.29) 420 0.38 (1,408) (1.28) Gains (losses) on purchases and sales of business interests (pre-tax) 24 0.02 115 0.10 51 0.05 (44) (0.04) Tax effect on gains (losses) on purchases and sales of business interests (1) — (24) (0.02) 67 0.06 6 0.01 Less: Gains (losses) on purchases and sales of business interests (net of tax) 23 0.02 91 0.08 118 0.11 (37) (0.03) Gains (losses) on equity securities (pre-tax) 1,935 1.76 665 0.61 76 0.07 1,921 1.75 Tax effect on gains (losses) on equity securities(a)(b) (3) — (27) (0.02) (17) (0.02) 128 0.12 Less: Gains (losses) on equity securities (net of tax) 1,933 1.76 638 0.58 58 0.05 2,049 1.87 Restructuring & other (pre-tax) (665) (0.61) 14 0.01 (918) (0.83) (380) (0.35) Tax effect on restructuring & other 145 0.13 (1) — 199 0.18 35 0.03 Less: Restructuring & other (net of tax) (520) (0.47) 14 0.01 (719) (0.65) (346) (0.31) Debt extinguishment costs (pre-tax) (465) (0.42) (5,108) (4.65) (465) (0.42) (6,524) (5.94) Tax effect on debt extinguishment costs 68 0.06 133 0.12 68 0.06 430 0.39 Less: Debt extinguishment costs (net of tax) (397) (0.36) (4,975) (4.53) (397) (0.36) (6,094) (5.55) Separation costs (pre-tax) (419) (0.38) — — (973) (0.88) — — Tax effect on separation costs 18 0.02 — — 77 0.07 — — Less: Separation costs (net of tax) (401) (0.37) — — (896) (0.81) — — Steam asset sale impairment (pre-tax) 1 — — — (824) (0.75) — — Tax effect on Steam asset sale impairment — — — — 84 0.08 — — Less: Steam asset sale impairment (net of tax) — — — — (740) (0.67) — — Russia and Ukraine charges (pre-tax) — — — — (263) (0.24) — — Tax effect on Russia and Ukraine charges — — — — 15 0.01 — — Less: Russia and Ukraine charges (net of tax) — — — — (248) (0.23) — — Less: Accretion of redeemable noncontrolling interest (pre-tax and net of tax) — — — — — — (9) (0.01) Less: Accretion of preferred share repurchase (pre-tax and net of tax) — — — — 3 — — — Less: U.S. and foreign tax law change enactment 95 0.09 — — 58 0.05 8 0.01 Less: Tax loss related to GECAS transaction — — (11) (0.01) — — (54) (0.05) Adjusted earnings (loss) per share (Non-GAAP) $ 1,360 1.24 $ 896 0.82 52% 51% $ 2,881 2.62 $ 1,876 1.71 54% 53% * Non-GAAP Financial Measure (a) Includes tax benefits available to offset the tax on gains in equity securities. (b) Includes related tax valuation allowances. Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total. The service cost for our pension and other benefit plans are included in Adjusted earnings*, which represents the ongoing cost of providing pension benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance. We believe the retained costs in Adjusted earnings* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability. -- 28 of 39 -- 29 Adjusted earnings (loss) and Adjusted earnings (loss) per share excluding GE HealthCare ADJUSTED EARNINGS (LOSS) EXCLUDING GE HEALTHCARE (NON-GAAP) 1Q'22 2022 (Dollars in millions, per-share amounts in dollars) Earnings EPS Earnings EPS Earnings (loss) from continuing operations excluding GE HealthCare (GAAP) $ (1,182) (1.07) $ (1,211) (1.11) Insurance earnings (loss) (pre-tax) 227 0.21 65 0.06 Tax effect on Insurance earnings (loss) (49) (0.04) (21) (0.02) Less: Insurance earnings (loss) (net of tax) 178 0.16 44 0.04 Earnings (loss) per share excluding Insurance and GE HealthCare (Non-GAAP) $ (1,360) (1.24) $ (1,255) (1.15) Non-operating benefit (cost) income (pre-tax) (GAAP) 105 0.10 409 0.37 Tax effect on non-operating benefit (cost) income (22) (0.02) (86) (0.08) Less: Non-operating benefit (cost) income (net of tax) 83 0.08 323 0.30 Gains (losses) on purchases and sales of business interests (pre-tax) 4 — 45 0.04 Tax effect on gains (losses) on purchases and sales of business interests (1) — 57 0.05 Less: Gains (losses) on purchases and sales of business interests (net of tax) 3 — 102 0.09 Gains (losses) on equity securities (pre-tax) (219) (0.20) 76 0.07 Tax effect on gains (losses) on equity securities(a)(b) (20) (0.02) (17) (0.02) Less: Gains (losses) on equity securities (net of tax) (239) (0.22) 58 0.05 Restructuring & other (pre-tax) (35) (0.03) (806) (0.74) Tax effect on restructuring & other 8 0.01 176 0.16 Less: Restructuring & other (net of tax) (27) (0.02) (630) (0.58) Debt extinguishment costs (pre-tax) — — (465) (0.42) Tax effect on debt extinguishment costs — — 68 0.06 Less: Debt extinguishment costs (net of tax) — — (397) (0.36) Separation costs (pre-tax) (99) (0.09) (715) (0.65) Tax effect on separation costs (24) (0.02) 23 0.02 Less: Separation costs (net of tax) (123) (0.11) (692) (0.63) Steam asset sale impairment (pre-tax) (824) (0.75) (824) (0.75) Tax effect on Steam asset sale impairment 84 0.08 84 0.08 Less: Steam asset sale impairment (net of tax) (740) (0.67) (740) (0.68) Russia and Ukraine charges (pre-tax) (230) (0.21) (263) (0.24) Tax effect on Russia and Ukraine charges 15 0.01 15 0.01 Less: Russia and Ukraine charges (net of tax) (215) (0.20) (248) (0.23) Less: Accretion of preferred share repurchase (pre-tax and net of tax) — — 3 — Less: U.S. and foreign tax law change enactment — — 126 0.11 Adjusted earnings (loss) per share excluding GE HealthCare (Non-GAAP) $ (102) (0.09) $ 839 0.77 * Non-GAAP Financial Measure (a) Includes tax benefits available to offset the tax on gains in equity securities. (b) Includes related tax valuation allowances. Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total. The service cost for our pension and other benefit plans are included in Adjusted earnings*, which represents the ongoing cost of providing pension benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance. We believe the retained costs in Adjusted earnings* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023. -- 29 of 39 -- Adjusted tax rate and Adjusted earnings from continuing operations before income taxes * Non-GAAP Financial Measure We believe the retained costs in the Adjusted income tax rate* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability. ADJUSTED TAX RATE (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Earnings (loss) from continuing operations before taxes (GAAP) $ 2,237 $ (3,467) $ 1,412 $ (3,683) Less: Insurance earnings (26) 140 65 570 Earnings (loss) from continuing operations before taxes, excluding Insurance (Non-GAAP) $ 2,263 $ (3,607) F $ 1,347 $ (4,252) F Less: non-operating benefit (cost) income 136 (408) 532 (1,782) Less: gains (losses) on purchases and sales of business interests 24 115 51 (44) Less: gains (losses) on equity securities 1,935 665 76 1,921 Less: restructuring & other (665) 14 (918) (380) Less: debt extinguishment costs (465) (5,108) (465) (6,524) Less: separation costs (419) — (973) — Less: Steam asset sale impairment 1 — (824) — Less: Russia and Ukraine charges — — (263) — Adjusted earnings (loss) from continuing operations before income taxes (Non-GAAP) $ 1,717 $ 1,115 54 % $ 4,131 $ 2,558 61 % Provision (benefit) for income taxes (GAAP) (65) 37 476 (286) Less: taxes on Insurance earnings (3) 30 21 126 Less: taxes on non-operating benefit (cost) income 29 (86) 112 (374) Less: taxes on gains (losses) on purchases and sales of business interests 1 24 (67) (6) Less: taxes on gains (losses) on equity securities 3 27 17 (128) Less: taxes on restructuring & other (145) 1 (199) (35) Less: taxes on debt extinguishment costs (68) (133) (68) (430) Less: taxes on separation costs (18) — (77) — Less: taxes on Steam asset sale impairment — — (84) — Less: taxes on Russia and Ukraine charges — — (15) — Less: U.S. and foreign tax law change enactment (95) — (58) (8) Less: tax loss related to GECAS transaction — 11 — 54 Adjusted provision (benefit) for income taxes (Non-GAAP) $ 232 $ 162 43 % $ 893 $ 516 73 % Income tax rate (GAAP) (2.9) % (1.1) % 33.7 % 7.8 % Adjusted income tax rate (Non-GAAP) 13.5 % 14.5 % 21.6 % 20.2 % ADJUSTED EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 4Q'22 4Q'21 V% 2022 2021 V% Adjusted profit (loss) (Non-GAAP) $ 2,162 $ 1,575 37 % $ 5,835 $ 4,608 27 % Add: interest and other financial charges (ex EFS, ex Insurance) (408) (410) (1,558) (1,817) Less: noncontrolling interests (16) (1) (67) 71 Less: EFS benefit from taxes 53 51 213 162 Adjusted earnings (loss) from continuing operations before income taxes (Non-GAAP) $ 1,717 $ 1,115 54 % $ 4,131 $ 2,558 61 % 30 -- 30 of 39 -- FREE CASH FLOWS (FCF) (NON-GAAP) (Dollars in millions) 4Q'22 4Q'21 V$ 2022 2021 V$ CFOA (GAAP) $ 4,571 $ 2,415 $ 2,156 $ 5,864 $ 888 $ 4,976 Less: Insurance CFOA 88 46 136 86 CFOA excluding Insurance (Non-GAAP) $ 4,483 $ 2,369 $ 2,114 $ 5,728 $ 802 $ 4,926 Add: gross additions to property, plant and equipment(a) (414) (355) (1,371) (1,250) Add: gross additions to internal-use software(a) (35) (33) (113) (111) Less: separation cash expenditures (143) — (261) — Less: Corporate restructuring cash expenditures (38) — (38) — Less: taxes related to business sales (71) — (214) (6) Less: CFOA impact from factoring programs discontinued in 2021 — (2,041) — (5,108) Less: CFOA impact from receivables factoring and supply chain finance eliminations — 314 — 2,666 Free cash flows (Non-GAAP) $ 4,286 $ 3,708 $ 578 $ 4,758 $ 1,889 $ 2,869 Less: prior period CFOA impact from factoring programs discontinued in 2021(b) — — — (739) Free cash flows excluding discontinued factoring (Non-GAAP) $ 4,286 $ 3,708 $ 578 $ 4,758 $ 2,628 $ 2,130 FREE CASH FLOWS (FCF) EXCLUDING GE HEALTHCARE (NON-GAAP) (Dollars in millions) 1Q'22 2022 CFOA excluding GE HealthCare (GAAP) $ (924) $ 4,023 Less: Insurance CFOA (15) 136 CFOA excluding Insurance and GE HealthCare (Non-GAAP) $ (909) $ 3,887 Add: gross additions to property, plant and equipment(a) (239) (1,061) Add: gross additions to internal-use software(a) (22) (113) Less: separation cash expenditures (3) (178) Less: Corporate restructuring cash expenditures — (38) Less: taxes related to business sales — (129) Free cash flows excluding GE HealthCare (Non-GAAP) $ (1,169) $ 3,059 31 Free cash flows (FCF) (including and excluding discontinued factoring) and Free cash flows (FCF) excluding GE HealthCare * Non-GAAP Financial Measure (a) Included in Gross CAPEX (b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued. We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023. -- 31 of 39 -- 32 Free cash flows (FCF) by quarter (including and excluding discontinued factoring) FREE CASH FLOWS (FCF) (NON-GAAP) (Dollars in millions) 1Q'22 2Q'22 3Q'22 4Q'22 2022 CFOA (GAAP) $ (535) $ 508 $ 1,320 $ 4,571 $ 5,864 Less: CFOA from insurance (15) 70 (7) 88 136 CFOA excluding Insurance (Non-GAAP) $ (520) $ 438 $ 1,328 $ 4,483 $ 5,728 Add: gross additions to property, plant and equipment(a) (340) (320) (297) (414) (1,371) Add: gross additions to internal-use software(a) (23) (26) (30) (35) (113) Less: separation cash expenditures (3) (20) (96) (143) (261) Less: Corporate restructuring cash expenditures — — — (38) (38) Less: taxes related to business sales — (50) (93) (71) (214) Free cash flows (Non-GAAP) $ (880) $ 162 $ 1,189 $ 4,286 $ 4,758 Less: prior period CFOA impact from factoring programs discontinued in 2021(b) — — — — — Free cash flows excluding discontinued factoring (Non-GAAP) $ (880) $ 162 $ 1,189 $ 4,286 $ 4,758 FREE CASH FLOWS (FCF) (NON-GAAP) (Dollars in millions) 1Q'21 2Q'21 3Q'21 4Q'21 2021 CFOA (GAAP) $ (2,640) $ (351) $ 1,464 $ 2,415 $ 888 Less: CFOA from insurance 60 (16) (4) 46 86 CFOA excluding Insurance (Non-GAAP) $ (2,699) $ (336) $ 1,467 $ 2,369 $ 802 Add: gross additions to property, plant and equipment(a) (332) (267) (296) (355) (1,250) Add: gross additions to internal-use software(a) (24) (26) (29) (33) (111) Less: CFOA impact from factoring programs discontinued in 2021 — (2,706) (362) (2,041) (5,108) Less: CFOA impact from receivables factoring and supply chain finance eliminations 306 1,884 161 314 2,666 Less: taxes related to business sales — (6) — — (6) Free cash flows (Non-GAAP) $ (3,361) $ 199 $ 1,343 $ 3,708 $ 1,889 Less: prior period CFOA impact from factoring programs discontinued in 2021(b) (778) 67 (28) — (739) Free cash flows excluding discontinued factoring (Non-GAAP) $ (2,583) $ 132 $ 1,371 $ 3,708 $ 2,628 * Non-GAAP Financial Measure (a) Included in Gross CAPEX (b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued. We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021. -- 32 of 39 -- 33 Free cash flows (FCF) by segment (including and excluding discontinued factoring) 2022 FREE CASH FLOWS (FCF) (Non-GAAP) (Dollars in millions) Aerospace Renewables Power HealthCare Corporate Total Company CFOA (GAAP) $ 5,514 $ (1,759) $ 2,078 $ 2,435 $ (2,404) $ 5,864 Less: Insurance CFOA — — — — 136 136 CFOA excluding Insurance (Non-GAAP) $ 5,514 $ (1,759) $ 2,078 $ 2,435 $ (2,540) $ 5,728 Add: gross additions to property, plant and equipment(a) (543) (275) (210) (310) (34) (1,371) Add: gross additions to internal-use software(a) (81) (7) (18) — (7) (113) Less: separation cash expenditures — — — — (261) (261) Less: Corporate restructuring cash expenditures — — — — (38) (38) Less: taxes related to business sales — — — — (214) (214) Free cash flows (Non-GAAP) $ 4,890 $ (2,040) $ 1,850 $ 2,125 $ (2,068) $ 4,758 Less: prior period CFOA impact from factoring programs discontinued in 2021(b) — — — — — — Free cash flows excluding discontinued factoring (Non-GAAP) $ 4,890 $ (2,040) $ 1,850 $ 2,125 $ (2,068) $ 4,758 2021 FREE CASH FLOWS (FCF) (Non-GAAP) (Dollars in millions) Aerospace Renewables Power HealthCare Corporate Total Company CFOA (GAAP) $ 2,815 $ (1,576) $ 24 $ 1,471 $ (1,846) $ 888 Less: Insurance CFOA — — — — 86 86 CFOA excluding Insurance (Non-GAAP) $ 2,815 $ (1,576) $ 24 $ 1,471 $ (1,933) $ 802 Add: gross additions to property, plant and equipment(a) (445) (349) (189) (242) (25) (1,250) Add: gross additions to internal-use software(a) (61) (9) (23) (6) (13) (111) Less: CFOA impact from factoring programs discontinued in 2021 (2,006) (539) (1,117) (1,481) 35 (5,108) Less: CFOA impact from receivables factoring and supply chain finance eliminations — — — — 2,666 2,666 Less: taxes related to business sales — — — — (6) (6) Free cash flows (Non-GAAP) $ 4,315 $ (1,395) $ 929 $ 2,705 $ (4,665) $ 1,889 Less: prior period CFOA impact from factoring programs discontinued in 2021(b) (314) (195) (232) — 2 (739) Free cash flows excluding discontinued factoring (Non-GAAP) $ 4,629 $ (1,200) $ 1,161 $ 2,705 $ (4,667) $ 2,628 * Non-GAAP Financial Measure (a) Included in Gross CAPEX (b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued. We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021. -- 33 of 39 -- Adjusted Corporate costs 34 CORPORATE REVENUES AND PROFIT (COST) (Dollars in millions) 4Q'22 4Q'21 V% 2022 2021 V% Corporate revenues $ 247 $ 253 $ 882 $ 945 Insurance revenues 775 811 2,954 3,106 Eliminations and other (260) (319) (1,030) (1,490) Total Corporate revenues $ 762 $ 745 2 % $ 2,806 $ 2,561 10 % Gains (losses) on purchases and sales of business interests $ 24 $ 115 $ 51 $ (44) Gains (losses) on equity securities 1,935 665 76 1,921 Restructuring and other charges (665) 14 (918) (380) Separation costs (419) — (973) — Steam asset sale impairment 1 — (824) — Russia and Ukraine charges — — (263) — Insurance profit (loss) (27) 140 60 566 Adjusted total Corporate operating costs (Non-GAAP) (314) (403) (621) (1,170) Total Corporate operating profit (cost) (GAAP) $ 533 $ 531 $ (3,413) $ 892 Less: gains (losses), impairments, Insurance, and restructuring & other 848 934 (2,792) 2,062 Adjusted total Corporate operating costs (Non-GAAP) $ (314) $ (403) 22 % $ (621) $ (1,170) 47 % Functions & operations $ (310) $ (307) $ (568) $ (848) Environmental, health and safety (EHS) and other items (14) (118) (94) (302) Eliminations 9 22 41 (20) Adjusted total Corporate operating costs (Non-GAAP) $ (314) $ (403) 22 % $ (621) $ (1,170) 47 % * Non-GAAP Financial Measure Adjusted total Corporate operating costs* excludes gains (losses) on purchases and sales of business interests, significant, higher-cost restructuring programs, separation costs, gains (losses) on equity securities, impairments and our run-off Insurance business profit. We believe that adjusting Corporate costs to exclude the effects of items that are not closely associated with ongoing Corporate operations provides management and investors with a meaningful measure that increases the period-to-period comparability of our ongoing Corporate costs. -- 34 of 39 -- GE, including GE HealthCare - net debt 35 * Non-GAAP Financial Measure (a) We are including this calculation to provide another market view to GE’s leverage. (b) Represents the total net deficit status of principal pension plans, other pension plans and retiree benefit plans. (c) We are including this calculation to provide a view aligned to credit rating methodology. Market Aligned Approach • Measure introduced in 4Q’21 to provide another market view to GE’s leverage. Rating Agency Aligned Approach • Measure introduced in 2018. Aligned to credit rating methodology. NET DEBT (NON-GAAP) (Dollars in millions) December 31, 2022 Total consolidated GE borrowings (GAAP) 32,350 100% of preferred stock 5,795 Deduction for 100% of GE cash, cash equivalents and restricted cash (17,262) Total GE consolidated net debt - market aligned (Non-GAAP)(a) 20,884 NET DEBT (NON-GAAP) (Dollars in millions) December 31, 2022 Total consolidated GE borrowings (GAAP) 32,350 Pension and principal retiree benefit plan liabilities (pre-tax)(b) 11,145 Less: taxes at 21% 2,340 Pension and principal retiree benefit plan liabilities (net of tax) 8,805 GE operating lease liabilities 2,393 GE Industrial preferred stock 5,795 Less: 50% of GE preferred stock 2,897 50% GE preferred stock 2,897 Short-term off-book factoring 100 Deduction for GE cash, cash equivalents and restricted cash 17,262 Less: 25% of GE cash, cash equivalents, and restricted cash (4,315) Deduction for 75% of GE cash, cash equivalents and restricted cash (12,946) Total GE consolidated net debt - (Non-GAAP)(c) 33,599 -- 35 of 39 -- GE, excluding GE HealthCare - net debt 36 * Non-GAAP Financial Measure (a) Assumes $1,451MM of cash on GE HealthCare’s books as of 12/31. (b) We are including this calculation to provide another market view to GE’s leverage. We are also presenting this measure excluding the net debt of GE HealthCare to provide investors with a relevant comparison for GE's future net debt following the GE HealthCare spin-off in January 2023. (c) Of the $2,000MM term loan that GE HealthCare drew down on January 3, 2023, GE HealthCare retained $349MM (to begin its operations with cash of $1,800MM). GE HealthCare distributed to GE the remaining $1,651MM of the draw down. (d) Represents the total net deficit status of principal pension plans, other pension plans and retiree benefit plans. (e) We are including this calculation to provide a view aligned to credit rating methodology. We are also presenting this measure excluding the net debt of GE HealthCare to provide investors with a relevant comparison for GE's future net debt following the GE HealthCare spin-off in January 2023. Market Aligned Approach • Measure introduced in 4Q’21 to provide another market view to GE’s leverage. Rating Agency Aligned Approach • Measure introduced in 2018. Aligned to credit rating methodology. NET DEBT (NON-GAAP) excluding GE HealthCare (Dollars in millions) Total consolidated GE borrowings (GAAP) 24,059 100% of preferred stock 5,795 Deduction for 100% of GE cash, cash equivalents and restricted cash(a) (15,810) Total GE excluding GE HealthCare net debt - (Non-GAAP)(b) 14,044 Cash Distribution from GE HealthCare after drawing term loan on 1/3/23(c) (1,651) Total GE excluding GE HealthCare net debt - (Non-GAAP) with term loan(b) 12,392 NET DEBT (NON-GAAP) excluding GE HealthCare (Dollars in millions) Total consolidated GE borrowings (GAAP) 24,059 Pension and principal retiree benefit plan liabilities (pre-tax)(d) 6,923 Less: taxes at 21% 1,454 Pension and principal retiree benefit plan liabilities (net of tax) 5,469 GE operating lease liabilities 2,106 GE Industrial preferred stock 5,795 Less: 50% of GE preferred stock 2,897 50% GE preferred stock 2,897 Short-term off-book factoring 98 Deduction for GE cash, cash equivalents and restricted cash(a) 15,810 Less: 25% of GE cash, cash equivalents, and restricted cash (3,953) Deduction for 75% of GE cash, cash equivalents and restricted cash (11,858) Total GE excluding GE HealthCare net debt - (Non-GAAP)(e) 22,772 75% of Cash Distribution from GE HealthCare after drawing term loan on 1/3/23(c) (1,238) Total GE excluding GE HealthCare net debt - (Non-GAAP) with term loan(e) 21,533 -- 36 of 39 -- GE, including GE HealthCare - EBITDA & leverage * Non-GAAP Financial Measure (a) Other items are mainly comprised of adjustments for gains and out of segment restructuring (b) Rating Agency aligned adjustments are mainly comprised of adjusted other income, long-term fixed operating lease expense, stock-related compensation expense and out of segment restructuring that is not related to the GE HealthCare separation. We believe that providing both rating agency aligned leverage and market aligned leverage provides management and investors with useful measures to evaluate company leverage and debt. 37 GE LEVERAGE (NON-GAAP) (Dollars in millions) December 31, 2022 GE earnings (loss) from continuing operations before income taxes (GAAP) 1,412 Less: Insurance earnings before income taxes 60 Less: Interest and other financial charges (1,552) Less: Non-operating benefit costs 532 Less: Restructuring & other(a) (724) Less: Debt extinguishment costs (465) Less: Separation costs (973) Less: Russia and Ukraine charges (263) Add: EFS benefit from taxes 213 Less: Depreciation and amortization of property, plant and equipment and amortization of intangible assets (3,544) Total GE leverage EBITDA - MARKET ALIGNED (Non-GAAP) 8,555 Add: Rating Agency aligned adjustments(b) (94) Total GE leverage EBITDA - RATING AGENCY ALIGNED (Non-GAAP) 8,460 GE NET DEBT / EBITDA RATIO - MARKET ALIGNED (NON-GAAP) GE NET DEBT/EBITDA RATIO - RATING AGENCY ALIGNED (NON-GAAP) (Dollars in millions) December 31, 2022 (Dollars in millions) December 31, 2022 Net Debt - market aligned (Non-GAAP) 20,884 Net Debt - Rating Agency aligned (Non-GAAP) 33,599 Total GE leverage EBITDA - market aligned (Non-GAAP) 8,555 Total GE leverage EBITDA - Rating Agency aligned (Non-GAAP) 8,460 GE net debt/EBITDA ratio - market aligned (Non-GAAP) 2.4x GE net debt/EBITDA ratio - Rating Agency aligned (Non-GAAP) 4.0x Approaches • Market Aligned: Measure introduced in 4Q’21 to provide another market view to GE’s leverage. • Rating Agency Aligned: Measure introduced in 2018. Aligned to credit rating methodology. -- 37 of 39 -- GE, excluding GE HealthCare - EBITDA & leverage * Non-GAAP Financial Measure (a) Other items are mainly comprised of adjustments for gains and out of segment restructuring (b) Rating Agency aligned adjustments are mainly comprised of adjusted other income, long-term fixed operating lease expense, stock-related compensation expense and out of segment restructuring that is not related to the GE HealthCare separation. (c) Includes the benefit of a cash distribution received from GE HealthCare, in connection with the draw of the term loan, as part of the spin on January 3, 2023. We believe that providing both rating agency aligned leverage and market aligned leverage provides management and investors with useful measures to evaluate company leverage and debt. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023. 38 GE LEVERAGE (NON-GAAP) excluding GE HealthCare (Dollars in millions) GE earnings (loss) excluding GE HealthCare from continuing operations before income taxes (GAAP) (944) Less: Insurance earnings before income taxes 60 Less: Interest and other financial charges (1,423) Less: Non-operating benefit costs 409 Less: Restructuring & other(a) (668) Less: Debt extinguishment costs (465) Less: Separation costs (715) Less: Russia and Ukraine charges (263) Add: EFS benefit from taxes 213 Less: Depreciation and amortization of property, plant and equipment and amortization of intangible assets (2,904) Total GE leverage EBITDA excluding GE HealthCare - MARKET ALIGNED (Non-GAAP) 5,238 Add: Rating Agency aligned adjustments(b) (170) Total GE leverage EBITDA excluding GE HealthCare - RATING AGENCY ALIGNED (Non-GAAP) 5,068 GE NET DEBT / EBITDA RATIO - MARKET ALIGNED (NON-GAAP) excluding GE HealthCare(c) GE NET DEBT/EBITDA RATIO - RATING AGENCY ALIGNED (NON-GAAP) excluding GE HealthCare(c) (Dollars in millions) (Dollars in millions) Net Debt - market aligned (Non-GAAP) 12,392 Net Debt - Rating Agency aligned (Non-GAAP) 21,533 Total GE leverage EBITDA - market aligned (Non-GAAP) 5,238 Total GE leverage EBITDA - Rating Agency aligned (Non-GAAP) 5,068 GE net debt/EBITDA ratio - market aligned (Non-GAAP) 2.4x GE net debt/EBITDA ratio - Rating Agency aligned (Non-GAAP) 4.2x Approaches • Market Aligned: Measure introduced in 4Q’21 to provide another market view to GE’s leverage. • Rating Agency Aligned: Measure introduced in 2018. Aligned to credit rating methodology. -- 38 of 39 -- Upcoming calendar 2023 GE Investor Conference March 9, 2023 1Q'23 earnings April 25, 2023 Annual Shareholders Meeting May 3, 2023 2Q'23 earnings July 25, 2023 3Q'23 earnings October 24, 2023 4Q'23 earnings January 23, 2024 39 -- 39 of 39 --